English

INNOVATIVE CLINICAL SOLUTIONS LTD

EDGAR

Annual report (10-K) · filed 2002-06-06

28 filing records in this dataset, filed from 1996-06-14 to 2002-06-06. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

-26 million USD

2002-01-31 · USD

Exact inputs and evidence

Revenue: 29234000 USD Source
Revenue: 55239000 USD Source

Operating margin

0.37%

2002-01-31 · %

Exact inputs and evidence

Operating Income: -14310000 USD Source
Operating Income: -14214000 USD Source
Revenue: 29234000 USD Source
Revenue: 55239000 USD Source

Cash and cash equivalents: 1.26 million USD 2002-01-31 Source
Exact value

1260000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

29.2 million USD

2001-02-01 – 2002-01-31

Exact inputs and evidence

Revenue: 18708000 USD · 2001-02-01 – 2001-04-30 Source
Revenue: 18790000 USD · 2001-05-01 – 2001-07-31 Source
Revenue: 17741000 USD · 2001-08-01 – 2001-10-31 Source
Revenue: 29234000 USD · 2001-02-01 – 2002-01-31 Source
Revenue: 55239000 USD · 2001-02-01 – 2001-10-31 Source

Net income

-21.7 million USD

2001-02-01 – 2002-01-31

Exact inputs and evidence

Net income: -5907000 USD · 2001-02-01 – 2001-04-30 Source
Net income: -3500000 USD · 2001-05-01 – 2001-07-31 Source
Net income: -5812000 USD · 2001-08-01 – 2001-10-31 Source
Net income: -21712000 USD · 2001-02-01 – 2002-01-31 Source
Net income: -15219000 USD · 2001-02-01 – 2001-10-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2002-06-06.

Financial data available through: 2002-01-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2002-01-31
Operating income: 4 of 11 periods available· newest 2002-01-31
Net income: 9 of 11 periods available· newest 2002-01-31
Operating cash flow: 8 of 11 periods available· newest 2001-01-31
Capital expenditure: 8 of 11 periods available· newest 2001-01-31
Total assets: 7 of 11 periods available· newest 2002-01-31
Total liabilities: 7 of 11 periods available· newest 2002-01-31
Current assets: 7 of 11 periods available· newest 2002-01-31
Current liabilities: 7 of 11 periods available· newest 2002-01-31
Cash and cash equivalents: 9 of 11 periods available· newest 2002-01-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+133.7%

Prior period

USD 12.51 million

2000-02-01 – 2001-01-31
Current period

USD 29.23 million

2001-02-01 – 2002-01-31

Exact inputs and evidence

29234000 − 12511000 = 16723000 USD

12511000 USD · 2000-02-01 – 2001-01-31
Inspect prior input Prior source
29234000 USD · 2001-02-01 – 2002-01-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · INNOVATIVE CLINICAL SOLUTIONS LTD · 2002-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Year-over-year change in Revenue: 16723000 USD Concept: fundies:Revenue Period: 2001-02-01 to 2002-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 29234000 USD (2001-02-01 to 2002-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-02-023293.txt#3106 Input fundies:Revenue: 12511000 USD (2000-02-01 to 2001-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-02-023293.txt#3106
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 5.72 million

Prior period

−USD 27.43 million

2000-02-01 – 2001-01-31
Current period

−USD 21.71 million

2001-02-01 – 2002-01-31

Exact inputs and evidence

-21712000 − -27429000 = 5717000 USD

-27429000 USD · 2000-02-01 – 2001-01-31
Inspect prior input Prior source
-21712000 USD · 2001-02-01 – 2002-01-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · INNOVATIVE CLINICAL SOLUTIONS LTD · 2002-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Year-over-year change in Net income: 5717000 USD Concept: fundies:NetIncome Period: 2001-02-01 to 2002-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -21712000 USD (2001-02-01 to 2002-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-02-023293.txt#3141 Input fundies:NetIncome: -27429000 USD (2000-02-01 to 2001-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-02-023293.txt#3141
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2002 2001-02-01 – 2002-01-31

Revenue USD 29.23 million 100% of revenue
Operating costs Derived USD 43.54 million 149% of revenue
Operating income −USD 14.31 million −49% of revenue
Tax, interest and other Derived USD 7.4 million 25% of revenue
Net income −USD 21.71 million −74% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Not shown: operating income or net income is not reported.
1995 Not shown: operating income or net income is not reported.
1996 Not shown: operating income or net income is not reported.
1997 Not shown: operating income or net income is not reported.
1998 Not shown: operating income or net income is not reported.
1999 Operating loss: operating costs were 113% of revenue.
2000 Operating loss: operating costs were 176% of revenue.
2001 Operating loss: operating costs were 168% of revenue.
2002 Operating loss: operating costs were 149% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1993-02-01 – 1994-01-31	2446821	Unavailable	Unavailable	Unavailable	-1296737	-1441055 Derived	Source 1993-02-01 – 1994-01-31: 2446821 USD Inspect Revenue Open source 1993-02-01 – 1994-01-31: -1296737 USD Inspect Net Income Open source 1993-02-01 – 1994-01-31: -1333707 USD Inspect Operating Cash Flow Open source 1993-02-01 – 1994-01-31: 107348 USD Inspect Capital Expenditure Open source
1995 1994-02-01 – 1995-01-31	84085125	Unavailable	Unavailable	Unavailable	-8093740	-1513712 Derived	Source 1994-02-01 – 1995-01-31: 84085125 USD Inspect Revenue Open source 1994-02-01 – 1995-01-31: -8093740 USD Inspect Net Income Open source 1994-02-01 – 1995-01-31: -135082 USD Inspect Operating Cash Flow Open source 1994-02-01 – 1995-01-31: 1378630 USD Inspect Capital Expenditure Open source
1996 1995-02-01 – 1996-01-31	10715236	Unavailable	Unavailable	Unavailable	-1176228	-1949772 Derived	Source 1995-02-01 – 1996-01-31: 10715236 USD Inspect Revenue Open source 1995-02-01 – 1996-01-31: -1176228 USD Inspect Net Income Open source 1995-02-01 – 1996-01-31: -1765312 USD Inspect Operating Cash Flow Open source 1995-02-01 – 1996-01-31: 184460 USD Inspect Capital Expenditure Open source
1997 1996-02-01 – 1997-01-31	165756000	Unavailable	Unavailable	Unavailable	15290000	-40000 Derived	Source 1996-02-01 – 1997-01-31: 165756000 USD Inspect Revenue Open source 1996-02-01 – 1997-01-31: 15290000 USD Inspect Net Income Open source 1996-02-01 – 1997-01-31: 5647000 USD Inspect Operating Cash Flow Open source 1996-02-01 – 1997-01-31: 5687000 USD Inspect Capital Expenditure Open source
1998 1997-02-01 – 1998-01-31	281179000	Unavailable	Unavailable	Unavailable	10299000	-12532000 Derived	Source 1997-02-01 – 1998-01-31: 281179000 USD Inspect Revenue Open source 1997-02-01 – 1998-01-31: 10299000 USD Inspect Net Income Open source 1997-02-01 – 1998-01-31: -2284000 USD Inspect Operating Cash Flow Open source 1997-02-01 – 1998-01-31: 10248000 USD Inspect Capital Expenditure Open source
1999 1998-02-01 – 1999-01-31	291278000	328798000 Derived	-37520000	93240000 Derived	-130760000	-11505000 Derived	Source 1998-02-01 – 1999-01-31: 291278000 USD Inspect Revenue Open source 1998-02-01 – 1999-01-31: -37520000 USD Inspect Operating Income Open source 1998-02-01 – 1999-01-31: -130760000 USD Inspect Net Income Open source 1998-02-01 – 1999-01-31: -4904000 USD Inspect Operating Cash Flow Open source 1998-02-01 – 1999-01-31: 6601000 USD Inspect Capital Expenditure Open source
2000 1999-02-01 – 2000-01-31	27560000	48592000 Derived	-21032000	-93108000 Derived	72076000	-22580000 Derived	Source 1999-02-01 – 2000-01-31: 27560000 USD Inspect Revenue Open source 1999-02-01 – 2000-01-31: -21032000 USD Inspect Operating Income Open source 1999-02-01 – 2000-01-31: 72076000 USD Inspect Net Income Open source 1999-02-01 – 2000-01-31: -22033000 USD Inspect Operating Cash Flow Open source 1999-02-01 – 2000-01-31: 547000 USD Inspect Capital Expenditure Open source
2001 2000-02-01 – 2001-01-31	12511000	21072000 Derived	-8561000	18868000 Derived	-27429000	-3102000 Derived	Source 2000-02-01 – 2001-01-31: 12511000 USD Inspect Revenue Open source 2000-02-01 – 2001-01-31: -8561000 USD Inspect Operating Income Open source 2000-02-01 – 2001-01-31: -27429000 USD Inspect Net Income Open source 2000-02-01 – 2001-01-31: -2869000 USD Inspect Operating Cash Flow Open source 2000-02-01 – 2001-01-31: 233000 USD Inspect Capital Expenditure Open source
2002 2001-02-01 – 2002-01-31	29234000	43544000 Derived	-14310000	7402000 Derived	-21712000	Unavailable	Source 2001-02-01 – 2002-01-31: 29234000 USD Inspect Revenue Open source 2001-02-01 – 2002-01-31: -14310000 USD Inspect Operating Income Open source 2001-02-01 – 2002-01-31: -21712000 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 29.2M 2002

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-01-31	Revenue	2446821	Revenue: 2446821 Open source
19951995-01-31	Revenue	84085125	Revenue: 84085125 Open source
19961996-01-31	Revenue	10715236	Revenue: 10715236 Open source
19971997-01-31	Revenue	165756000	Revenue: 165756000 Open source
19981998-01-31	Revenue	281179000	Revenue: 281179000 Open source
19991999-01-31	Revenue	291278000	Revenue: 291278000 Open source
20002000-01-31	Revenue	27560000	Revenue: 27560000 Open source
20012001-01-31	Revenue	12511000	Revenue: 12511000 Open source
20022002-01-31	Revenue	29234000	Revenue: 29234000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

133.7% 2002

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-01-31	Year over year	No prior comparable period	Revenue: 2446821 Open source
19951995-01-31	Year over year	3,336.5%	Revenue: 84085125 Open source Revenue: 2446821 Open source
19961996-01-31	Year over year	-87.3%	Revenue: 10715236 Open source Revenue: 84085125 Open source
19971997-01-31	Year over year	1,446.9%	Revenue: 165756000 Open source Revenue: 10715236 Open source
19981998-01-31	Year over year	69.6%	Revenue: 281179000 Open source Revenue: 165756000 Open source
19991999-01-31	Year over year	3.6%	Revenue: 291278000 Open source Revenue: 281179000 Open source
20002000-01-31	Year over year	-90.5%	Revenue: 27560000 Open source Revenue: 291278000 Open source
20012001-01-31	Year over year	-54.6%	Revenue: 12511000 Open source Revenue: 27560000 Open source
20022002-01-31	Year over year	133.7%	Revenue: 29234000 Open source Revenue: 12511000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -48.9% 2002

Net margin -74.3% 2002

Free cash flow margin -24.8% 2001

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1994-01-31	Operating margin	Not reported	Revenue: 2446821 Open source
1995-01-31	Operating margin	Not reported	Revenue: 84085125 Open source
1996-01-31	Operating margin	Not reported	Revenue: 10715236 Open source
1997-01-31	Operating margin	Not reported	Revenue: 165756000 Open source
1998-01-31	Operating margin	Not reported	Revenue: 281179000 Open source
19991999-01-31	Operating margin	-12.9%	Operating Income: -37520000 Open source Revenue: 291278000 Open source
20002000-01-31	Operating margin	-76.3%	Operating Income: -21032000 Open source Revenue: 27560000 Open source
20012001-01-31	Operating margin	-68.4%	Operating Income: -8561000 Open source Revenue: 12511000 Open source
20022002-01-31	Operating margin	-48.9%	Operating Income: -14310000 Open source Revenue: 29234000 Open source
19941994-01-31	Net margin	-53%	Net Income: -1296737 Open source Revenue: 2446821 Open source
19951995-01-31	Net margin	-9.6%	Net Income: -8093740 Open source Revenue: 84085125 Open source
19961996-01-31	Net margin	-11%	Net Income: -1176228 Open source Revenue: 10715236 Open source
19971997-01-31	Net margin	9.2%	Net Income: 15290000 Open source Revenue: 165756000 Open source
19981998-01-31	Net margin	3.7%	Net Income: 10299000 Open source Revenue: 281179000 Open source
19991999-01-31	Net margin	-44.9%	Net Income: -130760000 Open source Revenue: 291278000 Open source
20002000-01-31	Net margin	261.5%	Net Income: 72076000 Open source Revenue: 27560000 Open source
20012001-01-31	Net margin	-219.2%	Net Income: -27429000 Open source Revenue: 12511000 Open source
20022002-01-31	Net margin	-74.3%	Net Income: -21712000 Open source Revenue: 29234000 Open source
19941994-01-31	Free cash flow margin	-58.9%	Revenue: 2446821 Open source Operating Cash Flow: -1333707 Open source Capital Expenditure: 107348 Open source
19951995-01-31	Free cash flow margin	-1.8%	Revenue: 84085125 Open source Operating Cash Flow: -135082 Open source Capital Expenditure: 1378630 Open source
19961996-01-31	Free cash flow margin	-18.2%	Revenue: 10715236 Open source Operating Cash Flow: -1765312 Open source Capital Expenditure: 184460 Open source
19971997-01-31	Free cash flow margin	-0%	Revenue: 165756000 Open source Operating Cash Flow: 5647000 Open source Capital Expenditure: 5687000 Open source
19981998-01-31	Free cash flow margin	-4.5%	Revenue: 281179000 Open source Operating Cash Flow: -2284000 Open source Capital Expenditure: 10248000 Open source
19991999-01-31	Free cash flow margin	-3.9%	Revenue: 291278000 Open source Operating Cash Flow: -4904000 Open source Capital Expenditure: 6601000 Open source
20002000-01-31	Free cash flow margin	-81.9%	Revenue: 27560000 Open source Operating Cash Flow: -22033000 Open source Capital Expenditure: 547000 Open source
20012001-01-31	Free cash flow margin	-24.8%	Revenue: 12511000 Open source Operating Cash Flow: -2869000 Open source Capital Expenditure: 233000 Open source
20022002-01-31	Free cash flow margin	Not reported	Revenue: 29234000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -2.9M 2001

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-01-31	Operating cash flow	-1333707	Operating Cash Flow: -1333707 Open source
19951995-01-31	Operating cash flow	-135082	Operating Cash Flow: -135082 Open source
19961996-01-31	Operating cash flow	-1765312	Operating Cash Flow: -1765312 Open source
19971997-01-31	Operating cash flow	5647000	Operating Cash Flow: 5647000 Open source
19981998-01-31	Operating cash flow	-2284000	Operating Cash Flow: -2284000 Open source
19991999-01-31	Operating cash flow	-4904000	Operating Cash Flow: -4904000 Open source
20002000-01-31	Operating cash flow	-22033000	Operating Cash Flow: -22033000 Open source
20012001-01-31	Operating cash flow	-2869000	Operating Cash Flow: -2869000 Open source
20022002-01-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -3.1M 2001

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-01-31	Free cash flow	-1441055	Operating Cash Flow: -1333707 Open source Capital Expenditure: 107348 Open source
19951995-01-31	Free cash flow	-1513712	Operating Cash Flow: -135082 Open source Capital Expenditure: 1378630 Open source
19961996-01-31	Free cash flow	-1949772	Operating Cash Flow: -1765312 Open source Capital Expenditure: 184460 Open source
19971997-01-31	Free cash flow	-40000	Operating Cash Flow: 5647000 Open source Capital Expenditure: 5687000 Open source
19981998-01-31	Free cash flow	-12532000	Operating Cash Flow: -2284000 Open source Capital Expenditure: 10248000 Open source
19991999-01-31	Free cash flow	-11505000	Operating Cash Flow: -4904000 Open source Capital Expenditure: 6601000 Open source
20002000-01-31	Free cash flow	-22580000	Operating Cash Flow: -22033000 Open source Capital Expenditure: 547000 Open source
20012001-01-31	Free cash flow	-3102000	Operating Cash Flow: -2869000 Open source Capital Expenditure: 233000 Open source
20022002-01-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

97.4% 2002

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-01-31	Liabilities / assets	Not reported	No source recorded
1995-01-31	Liabilities / assets	Not reported	No source recorded
19961996-01-31	Liabilities / assets	29.3%	Total Liabilities: 52798496 Open source Total Assets: 180007473 Open source
19971997-01-31	Liabilities / assets	50.9%	Total Liabilities: 159530508 Open source Total Assets: 313310205 Open source
19981998-01-31	Liabilities / assets	43.9%	Total Liabilities: 166125000 Open source Total Assets: 378160000 Open source
19991999-01-31	Liabilities / assets	58.1%	Total Liabilities: 146951000 Open source Total Assets: 252851000 Open source
20002000-01-31	Liabilities / assets	176.4%	Total Liabilities: 154033000 Open source Total Assets: 87311000 Open source
20012001-01-31	Liabilities / assets	61.1%	Total Liabilities: 35532000 Open source Total Assets: 58180000 Open source
20022002-01-31	Liabilities / assets	97.4%	Total Liabilities: 32259000 Open source Total Assets: 33118000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.45× 2002

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-01-31	Current assets / current liabilities	Not reported	No source recorded
1995-01-31	Current assets / current liabilities	Not reported	No source recorded
19961996-01-31	Current assets / current liabilities	2.74×	Current Assets: 69556906 Open source Current Liabilities: 25348061 Open source
19971997-01-31	Current assets / current liabilities	5.08×	Current Assets: 139189796 Open source Current Liabilities: 27379172 Open source
19981998-01-31	Current assets / current liabilities	3.03×	Current Assets: 129046000 Open source Current Liabilities: 42656000 Open source
19991999-01-31	Current assets / current liabilities	3.86×	Current Assets: 150077000 Open source Current Liabilities: 38892000 Open source
20002000-01-31	Current assets / current liabilities	0.38×	Current Assets: 56496000 Open source Current Liabilities: 149212000 Open source
20012001-01-31	Current assets / current liabilities	0.71×	Current Assets: 21701000 Open source Current Liabilities: 30375000 Open source
20022002-01-31	Current assets / current liabilities	0.45×	Current Assets: 13617000 Open source Current Liabilities: 30340000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1993-02-01 – 1994-01-31	−USD 1.3 million Exact value Exact value: -1296737 USD 1993-02-01 – 1994-01-31: -1296737 USD Inspect Net Income Open source Share or cite Citation for Net Income · INNOVATIVE CLINICAL SOLUTIONS LTD · 1994-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Net Income: -1296737 USD Concept: fundies:NetIncome Period: 1993-02-01 to 1994-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ANetIncome&period=1994-01-31&surface=latest&period_type=duration&start=1993-02-01&unit=USD&dimensions= Input fundies:NetIncome: -1296737 USD (1993-02-01 to 1994-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-97-000553.txt#2851 The citation records this snapshot. The page link may show a newer release later.	−USD 1.33 million Exact value Exact value: -1333707 USD 1993-02-01 – 1994-01-31: -1333707 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 1994-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Operating Cash Flow: -1333707 USD Concept: fundies:OperatingCashFlow Period: 1993-02-01 to 1994-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3AOperatingCashFlow&period=1994-01-31&surface=latest&period_type=duration&start=1993-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1333707 USD (1993-02-01 to 1994-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-97-000553.txt#2861 The citation records this snapshot. The page link may show a newer release later.	USD 107,348 Exact value Exact value: 107348 USD 1993-02-01 – 1994-01-31: 107348 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INNOVATIVE CLINICAL SOLUTIONS LTD · 1994-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Capital Expenditure: 107348 USD Concept: fundies:CapitalExpenditure Period: 1993-02-01 to 1994-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ACapitalExpenditure&period=1994-01-31&surface=latest&period_type=duration&start=1993-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 107348 USD (1993-02-01 to 1994-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-97-000553.txt#2865 The citation records this snapshot. The page link may show a newer release later.	−USD 1.44 million Calculation and evidence -1333707 − 107348 USD Exact free cash flow: -1441055 USD 1993-02-01 – 1994-01-31: -1333707 USD · Inspect Operating Cash Flow · Source 1993-02-01 – 1994-01-31: 107348 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 1994-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Free cash flow: -1441055 USD Concept: free-cash-flow Period: 1993-02-01 to 1994-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1333707 USD (1993-02-01 to 1994-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-97-000553.txt#2861 Input fundies:CapitalExpenditure: 107348 USD (1993-02-01 to 1994-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-97-000553.txt#2865 The citation records this snapshot. The page link may show a newer release later.
1995 1994-02-01 – 1995-01-31	−USD 8.09 million Exact value Exact value: -8093740 USD 1994-02-01 – 1995-01-31: -8093740 USD Inspect Net Income Open source Share or cite Citation for Net Income · INNOVATIVE CLINICAL SOLUTIONS LTD · 1995-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Net Income: -8093740 USD Concept: fundies:NetIncome Period: 1994-02-01 to 1995-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ANetIncome&period=1995-01-31&surface=latest&period_type=duration&start=1994-02-01&unit=USD&dimensions= Input fundies:NetIncome: -8093740 USD (1994-02-01 to 1995-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-98-000720.txt#1287 The citation records this snapshot. The page link may show a newer release later.	−USD 135,082 Exact value Exact value: -135082 USD 1994-02-01 – 1995-01-31: -135082 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 1995-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Operating Cash Flow: -135082 USD Concept: fundies:OperatingCashFlow Period: 1994-02-01 to 1995-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3AOperatingCashFlow&period=1995-01-31&surface=latest&period_type=duration&start=1994-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -135082 USD (1994-02-01 to 1995-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-98-000720.txt#1299 The citation records this snapshot. The page link may show a newer release later.	USD 1.38 million Exact value Exact value: 1378630 USD 1994-02-01 – 1995-01-31: 1378630 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INNOVATIVE CLINICAL SOLUTIONS LTD · 1995-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Capital Expenditure: 1378630 USD Concept: fundies:CapitalExpenditure Period: 1994-02-01 to 1995-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ACapitalExpenditure&period=1995-01-31&surface=latest&period_type=duration&start=1994-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1378630 USD (1994-02-01 to 1995-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-98-000720.txt#1301 The citation records this snapshot. The page link may show a newer release later.	−USD 1.51 million Calculation and evidence -135082 − 1378630 USD Exact free cash flow: -1513712 USD 1994-02-01 – 1995-01-31: -135082 USD · Inspect Operating Cash Flow · Source 1994-02-01 – 1995-01-31: 1378630 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 1995-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Free cash flow: -1513712 USD Concept: free-cash-flow Period: 1994-02-01 to 1995-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -135082 USD (1994-02-01 to 1995-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-98-000720.txt#1299 Input fundies:CapitalExpenditure: 1378630 USD (1994-02-01 to 1995-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-98-000720.txt#1301 The citation records this snapshot. The page link may show a newer release later.
1996 1995-02-01 – 1996-01-31	−USD 1.18 million Exact value Exact value: -1176228 USD 1995-02-01 – 1996-01-31: -1176228 USD Inspect Net Income Open source Share or cite Citation for Net Income · INNOVATIVE CLINICAL SOLUTIONS LTD · 1996-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Net Income: -1176228 USD Concept: fundies:NetIncome Period: 1995-02-01 to 1996-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ANetIncome&period=1996-01-31&surface=latest&period_type=duration&start=1995-02-01&unit=USD&dimensions= Input fundies:NetIncome: -1176228 USD (1995-02-01 to 1996-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-97-000553.txt#2851 The citation records this snapshot. The page link may show a newer release later.	−USD 1.77 million Exact value Exact value: -1765312 USD 1995-02-01 – 1996-01-31: -1765312 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 1996-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Operating Cash Flow: -1765312 USD Concept: fundies:OperatingCashFlow Period: 1995-02-01 to 1996-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3AOperatingCashFlow&period=1996-01-31&surface=latest&period_type=duration&start=1995-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1765312 USD (1995-02-01 to 1996-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-97-000553.txt#2861 The citation records this snapshot. The page link may show a newer release later.	USD 184,460 Exact value Exact value: 184460 USD 1995-02-01 – 1996-01-31: 184460 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INNOVATIVE CLINICAL SOLUTIONS LTD · 1996-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Capital Expenditure: 184460 USD Concept: fundies:CapitalExpenditure Period: 1995-02-01 to 1996-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ACapitalExpenditure&period=1996-01-31&surface=latest&period_type=duration&start=1995-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 184460 USD (1995-02-01 to 1996-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-97-000553.txt#2865 The citation records this snapshot. The page link may show a newer release later.	−USD 1.95 million Calculation and evidence -1765312 − 184460 USD Exact free cash flow: -1949772 USD 1995-02-01 – 1996-01-31: -1765312 USD · Inspect Operating Cash Flow · Source 1995-02-01 – 1996-01-31: 184460 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 1996-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Free cash flow: -1949772 USD Concept: free-cash-flow Period: 1995-02-01 to 1996-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1765312 USD (1995-02-01 to 1996-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-97-000553.txt#2861 Input fundies:CapitalExpenditure: 184460 USD (1995-02-01 to 1996-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001029869-97-000553.txt#2865 The citation records this snapshot. The page link may show a newer release later.
1997 1996-02-01 – 1997-01-31	USD 15.29 million Exact value Exact value: 15290000 USD 1996-02-01 – 1997-01-31: 15290000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INNOVATIVE CLINICAL SOLUTIONS LTD · 1997-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Net Income: 15290000 USD Concept: fundies:NetIncome Period: 1996-02-01 to 1997-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ANetIncome&period=1997-01-31&surface=latest&period_type=duration&start=1996-02-01&unit=USD&dimensions= Input fundies:NetIncome: 15290000 USD (1996-02-01 to 1997-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001047469-99-017260.txt#3215 The citation records this snapshot. The page link may show a newer release later.	USD 5.65 million Exact value Exact value: 5647000 USD 1996-02-01 – 1997-01-31: 5647000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 1997-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Operating Cash Flow: 5647000 USD Concept: fundies:OperatingCashFlow Period: 1996-02-01 to 1997-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3AOperatingCashFlow&period=1997-01-31&surface=latest&period_type=duration&start=1996-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5647000 USD (1996-02-01 to 1997-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001047469-99-017260.txt#3231 The citation records this snapshot. The page link may show a newer release later.	USD 5.69 million Exact value Exact value: 5687000 USD 1996-02-01 – 1997-01-31: 5687000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INNOVATIVE CLINICAL SOLUTIONS LTD · 1997-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Capital Expenditure: 5687000 USD Concept: fundies:CapitalExpenditure Period: 1996-02-01 to 1997-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ACapitalExpenditure&period=1997-01-31&surface=latest&period_type=duration&start=1996-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5687000 USD (1996-02-01 to 1997-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001047469-99-017260.txt#3234 The citation records this snapshot. The page link may show a newer release later.	−USD 40,000 Calculation and evidence 5647000 − 5687000 USD Exact free cash flow: -40000 USD 1996-02-01 – 1997-01-31: 5647000 USD · Inspect Operating Cash Flow · Source 1996-02-01 – 1997-01-31: 5687000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 1997-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Free cash flow: -40000 USD Concept: free-cash-flow Period: 1996-02-01 to 1997-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5647000 USD (1996-02-01 to 1997-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001047469-99-017260.txt#3231 Input fundies:CapitalExpenditure: 5687000 USD (1996-02-01 to 1997-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0001047469-99-017260.txt#3234 The citation records this snapshot. The page link may show a newer release later.
1998 1997-02-01 – 1998-01-31	USD 10.3 million Exact value Exact value: 10299000 USD 1997-02-01 – 1998-01-31: 10299000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INNOVATIVE CLINICAL SOLUTIONS LTD · 1998-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Net Income: 10299000 USD Concept: fundies:NetIncome Period: 1997-02-01 to 1998-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ANetIncome&period=1998-01-31&surface=latest&period_type=duration&start=1997-02-01&unit=USD&dimensions= Input fundies:NetIncome: 10299000 USD (1997-02-01 to 1998-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-00-027025.txt#3290 The citation records this snapshot. The page link may show a newer release later.	−USD 2.28 million Exact value Exact value: -2284000 USD 1997-02-01 – 1998-01-31: -2284000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 1998-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Operating Cash Flow: -2284000 USD Concept: fundies:OperatingCashFlow Period: 1997-02-01 to 1998-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3AOperatingCashFlow&period=1998-01-31&surface=latest&period_type=duration&start=1997-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2284000 USD (1997-02-01 to 1998-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-00-027025.txt#3305 The citation records this snapshot. The page link may show a newer release later.	USD 10.25 million Exact value Exact value: 10248000 USD 1997-02-01 – 1998-01-31: 10248000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INNOVATIVE CLINICAL SOLUTIONS LTD · 1998-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Capital Expenditure: 10248000 USD Concept: fundies:CapitalExpenditure Period: 1997-02-01 to 1998-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ACapitalExpenditure&period=1998-01-31&surface=latest&period_type=duration&start=1997-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10248000 USD (1997-02-01 to 1998-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-00-027025.txt#3307 The citation records this snapshot. The page link may show a newer release later.	−USD 12.53 million Calculation and evidence -2284000 − 10248000 USD Exact free cash flow: -12532000 USD 1997-02-01 – 1998-01-31: -2284000 USD · Inspect Operating Cash Flow · Source 1997-02-01 – 1998-01-31: 10248000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 1998-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Free cash flow: -12532000 USD Concept: free-cash-flow Period: 1997-02-01 to 1998-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2284000 USD (1997-02-01 to 1998-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-00-027025.txt#3305 Input fundies:CapitalExpenditure: 10248000 USD (1997-02-01 to 1998-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-00-027025.txt#3307 The citation records this snapshot. The page link may show a newer release later.
1999 1998-02-01 – 1999-01-31	−USD 130.76 million Exact value Exact value: -130760000 USD 1998-02-01 – 1999-01-31: -130760000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INNOVATIVE CLINICAL SOLUTIONS LTD · 1999-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Net Income: -130760000 USD Concept: fundies:NetIncome Period: 1998-02-01 to 1999-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ANetIncome&period=1999-01-31&surface=latest&period_type=duration&start=1998-02-01&unit=USD&dimensions= Input fundies:NetIncome: -130760000 USD (1998-02-01 to 1999-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-01-527651.txt#2960 The citation records this snapshot. The page link may show a newer release later.	−USD 4.9 million Exact value Exact value: -4904000 USD 1998-02-01 – 1999-01-31: -4904000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 1999-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Operating Cash Flow: -4904000 USD Concept: fundies:OperatingCashFlow Period: 1998-02-01 to 1999-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3AOperatingCashFlow&period=1999-01-31&surface=latest&period_type=duration&start=1998-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4904000 USD (1998-02-01 to 1999-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-01-527651.txt#2987 The citation records this snapshot. The page link may show a newer release later.	USD 6.6 million Exact value Exact value: 6601000 USD 1998-02-01 – 1999-01-31: 6601000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INNOVATIVE CLINICAL SOLUTIONS LTD · 1999-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Capital Expenditure: 6601000 USD Concept: fundies:CapitalExpenditure Period: 1998-02-01 to 1999-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ACapitalExpenditure&period=1999-01-31&surface=latest&period_type=duration&start=1998-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6601000 USD (1998-02-01 to 1999-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-01-527651.txt#2989 The citation records this snapshot. The page link may show a newer release later.	−USD 11.51 million Calculation and evidence -4904000 − 6601000 USD Exact free cash flow: -11505000 USD 1998-02-01 – 1999-01-31: -4904000 USD · Inspect Operating Cash Flow · Source 1998-02-01 – 1999-01-31: 6601000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 1999-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Free cash flow: -11505000 USD Concept: free-cash-flow Period: 1998-02-01 to 1999-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4904000 USD (1998-02-01 to 1999-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-01-527651.txt#2987 Input fundies:CapitalExpenditure: 6601000 USD (1998-02-01 to 1999-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-01-527651.txt#2989 The citation records this snapshot. The page link may show a newer release later.
2000 1999-02-01 – 2000-01-31	USD 72.08 million Exact value Exact value: 72076000 USD 1999-02-01 – 2000-01-31: 72076000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INNOVATIVE CLINICAL SOLUTIONS LTD · 2000-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Net Income: 72076000 USD Concept: fundies:NetIncome Period: 1999-02-01 to 2000-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ANetIncome&period=2000-01-31&surface=latest&period_type=duration&start=1999-02-01&unit=USD&dimensions= Input fundies:NetIncome: 72076000 USD (1999-02-01 to 2000-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-02-023293.txt#3141 The citation records this snapshot. The page link may show a newer release later.	−USD 22.03 million Exact value Exact value: -22033000 USD 1999-02-01 – 2000-01-31: -22033000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 2000-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Operating Cash Flow: -22033000 USD Concept: fundies:OperatingCashFlow Period: 1999-02-01 to 2000-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3AOperatingCashFlow&period=2000-01-31&surface=latest&period_type=duration&start=1999-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22033000 USD (1999-02-01 to 2000-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-01-527651.txt#2987 The citation records this snapshot. The page link may show a newer release later.	USD 547,000 Exact value Exact value: 547000 USD 1999-02-01 – 2000-01-31: 547000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INNOVATIVE CLINICAL SOLUTIONS LTD · 2000-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Capital Expenditure: 547000 USD Concept: fundies:CapitalExpenditure Period: 1999-02-01 to 2000-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ACapitalExpenditure&period=2000-01-31&surface=latest&period_type=duration&start=1999-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 547000 USD (1999-02-01 to 2000-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-01-527651.txt#2989 The citation records this snapshot. The page link may show a newer release later.	−USD 22.58 million Calculation and evidence -22033000 − 547000 USD Exact free cash flow: -22580000 USD 1999-02-01 – 2000-01-31: -22033000 USD · Inspect Operating Cash Flow · Source 1999-02-01 – 2000-01-31: 547000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 2000-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Free cash flow: -22580000 USD Concept: free-cash-flow Period: 1999-02-01 to 2000-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22033000 USD (1999-02-01 to 2000-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-01-527651.txt#2987 Input fundies:CapitalExpenditure: 547000 USD (1999-02-01 to 2000-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-01-527651.txt#2989 The citation records this snapshot. The page link may show a newer release later.
2001 2000-02-01 – 2001-01-31	−USD 27.43 million Exact value Exact value: -27429000 USD 2000-02-01 – 2001-01-31: -27429000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INNOVATIVE CLINICAL SOLUTIONS LTD · 2001-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Net Income: -27429000 USD Concept: fundies:NetIncome Period: 2000-02-01 to 2001-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ANetIncome&period=2001-01-31&surface=latest&period_type=duration&start=2000-02-01&unit=USD&dimensions= Input fundies:NetIncome: -27429000 USD (2000-02-01 to 2001-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-02-023293.txt#3141 The citation records this snapshot. The page link may show a newer release later.	−USD 2.87 million Exact value Exact value: -2869000 USD 2000-02-01 – 2001-01-31: -2869000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 2001-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Operating Cash Flow: -2869000 USD Concept: fundies:OperatingCashFlow Period: 2000-02-01 to 2001-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3AOperatingCashFlow&period=2001-01-31&surface=latest&period_type=duration&start=2000-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2869000 USD (2000-02-01 to 2001-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-01-527651.txt#2987 The citation records this snapshot. The page link may show a newer release later.	USD 233,000 Exact value Exact value: 233000 USD 2000-02-01 – 2001-01-31: 233000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INNOVATIVE CLINICAL SOLUTIONS LTD · 2001-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Capital Expenditure: 233000 USD Concept: fundies:CapitalExpenditure Period: 2000-02-01 to 2001-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ACapitalExpenditure&period=2001-01-31&surface=latest&period_type=duration&start=2000-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 233000 USD (2000-02-01 to 2001-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-01-527651.txt#2989 The citation records this snapshot. The page link may show a newer release later.	−USD 3.1 million Calculation and evidence -2869000 − 233000 USD Exact free cash flow: -3102000 USD 2000-02-01 – 2001-01-31: -2869000 USD · Inspect Operating Cash Flow · Source 2000-02-01 – 2001-01-31: 233000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INNOVATIVE CLINICAL SOLUTIONS LTD · 2001-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Free cash flow: -3102000 USD Concept: free-cash-flow Period: 2000-02-01 to 2001-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2869000 USD (2000-02-01 to 2001-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-01-527651.txt#2987 Input fundies:CapitalExpenditure: 233000 USD (2000-02-01 to 2001-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-01-527651.txt#2989 The citation records this snapshot. The page link may show a newer release later.
2002 2001-02-01 – 2002-01-31	−USD 21.71 million Exact value Exact value: -21712000 USD 2001-02-01 – 2002-01-31: -21712000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INNOVATIVE CLINICAL SOLUTIONS LTD · 2002-01-31 INNOVATIVE CLINICAL SOLUTIONS LTD (edgar:1002022) Net Income: -21712000 USD Concept: fundies:NetIncome Period: 2001-02-01 to 2002-01-31 Values: Latest reported Published: 2026-11-02T15:47:06Z Snapshot: d624337b7d8335dad1f6ab7be1d1350e76002ff6200fb80c0a2e2229fbdbd9ed Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002022/explain?concept=fundies%3ANetIncome&period=2002-01-31&surface=latest&period_type=duration&start=2001-02-01&unit=USD&dimensions= Input fundies:NetIncome: -21712000 USD (2001-02-01 to 2002-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002022/0000912057-02-023293.txt#3141 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

28 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001002022, 1002022, edgar:1002022

Also known as PHYMATRIX CORP

INNOVATIVE CLINICAL SOLUTIONS LTD

Latest quarter

Revenue

Operating margin

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2002 2001-02-01 – 2002-01-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation